Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.805 USD | +2.24% | +5.96% | +112.86% |
May. 31 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
May. 31 | Larimar Therapeutics Shares Rise 15% Nomlabofusp Selected for FDA Program | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+112.86% | 612M | |
+18.13% | 125B | |
+13.24% | 108B | |
-7.38% | 24.21B | |
+2.01% | 22.78B | |
-10.65% | 17.96B | |
-41.74% | 16.43B | |
-12.48% | 16.37B | |
+0.93% | 13.58B | |
+26.55% | 11.66B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Guggenheim Adjusts Price Target on Larimar Therapeutics to $25 From $14, Maintains Buy Rating